Evidence map›Paper›PMID 31948306›Full record

Observational studyThe Journal of international medical research2020

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin.

Faying Yang, Jianhua Ma, Jianghou Wan, Wuhua Ha, Cheng Fang, Huaiquan Lu, Wei Zhang

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Faying YangDepartment of Urology, Zhangye People's Hospital Affiliated to Hexi University, Zhangye 734000, P. R. China.
Jianhua MaDepartment of Urology, The First Hospital of LanZhou University, LanZhou 730000, P. R. China.ORCID https://orcid.org/0000-0003-1697-4208
Jianghou WanDepartment of Urology, The First Hospital of LanZhou University, LanZhou 730000, P. R. China.
Wuhua HaDepartment of Urology, The First Hospital of LanZhou University, LanZhou 730000, P. R. China.
Cheng FangDepartment of Urology, The First Hospital of LanZhou University, LanZhou 730000, P. R. China.
Huaiquan LuDepartment of Urology, The First Hospital of LanZhou University, LanZhou 730000, P. R. China.
Wei Zhang
First Hospital of Lanzhou University · CNHexi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCell Line, TumorCytoplasmEpithelial-Mesenchymal TransitionHumansKallikreinsMaleNeoplasm InvasivenessNeoplasm MetastasisNeoplastic Cells, CirculatingPrimary Cell CultureProstate-Specific AntigenProstatic NeoplasmsRNA InterferenceRNA, Small InterferingSurvivinBiomarkers, TumorBIRC5 protein, humanKallikreinsKLK3 protein, humanProstate-Specific AntigenRNA, Small InterferingSurvivinVimentinVIM protein, humancirculating tumor cellsdiagnosisepithelial-mesenchymal transitionmetastasisprostate cancersurvivin

Identifiers

PMID31948306
PMCPMC7254165
OpenAlexW3000460221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.